Venrock Healthcare Capital Partners III sells 174,485 KalVista Pharmaceuticals shares.

KalVista Pharmaceuticals, Inc. (KALV) recently disclosed that Venrock Healthcare Capital Partners III, L.P., a 10% owner of the company, has executed several transactions involving the sale of shares. Specifically, the entity sold 3,183 shares at $19.12 per share on March 26, 2026, and sold an additional 174,485 shares at $16.95 per share on March 25, 2026. Additionally, 21,386 shares were sold at $17.76 per share on March 26, 2026, and 160 shares were sold at $17.53 per share on March 25, 2026. Furthermore, the entity sold 15,417 shares at $18.82 per share on March 26, 2026.